ERBB2 and breast carcinoma: ILBCs are typically oestrogen receptor (ER) and progesterone receptor (PR) positive and human epidermal growth factor receptor 2 (HER2) negative and are strongly associated with hormonal risk factors for breast cancer [4–7].